Inhibitor Therapeutics INTI
OTC INTI
$0.10 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Inhibitor Therapeutics (INTI) Long-Term Debt Issuances (2020 - 2022)

Updated

Inhibitor Therapeutics' Long-Term Debt Issuances was $180,000 in FY2022, up 2.3% from $176,000 in FY2021.

Analysis

Inhibitor Therapeutics (INTI) Long-Term Debt Issuances (2020 - 2022) Analysis & Trends

  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $176,000 in FY2021 (+220.0%) and $55,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.98 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Inhibitor Therapeutics 17.38 Mn 17.38 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 80,000.00
Jun 30, 2022 50,000.00
Mar 31, 2022 50,000.00
Jun 30, 2021 75,000.00
Mar 31, 2021 101,000.00
Dec 31, 2020 13,400.00
Jun 30, 2020 41,600.00
API Access

Inhibitor Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=INTI&period=max&api_key=YOUR_API_KEY